WO2010071541A1 - Nutritional supplement with specific amino acid profile - Google Patents
Nutritional supplement with specific amino acid profile Download PDFInfo
- Publication number
- WO2010071541A1 WO2010071541A1 PCT/SE2009/000517 SE2009000517W WO2010071541A1 WO 2010071541 A1 WO2010071541 A1 WO 2010071541A1 SE 2009000517 W SE2009000517 W SE 2009000517W WO 2010071541 A1 WO2010071541 A1 WO 2010071541A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- amount
- powder
- protein
- powder according
- amino acid
- Prior art date
Links
- 150000001413 amino acids Chemical class 0.000 title claims abstract description 50
- 235000015872 dietary supplement Nutrition 0.000 title description 2
- 239000000843 powder Substances 0.000 claims abstract description 78
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 65
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 65
- 239000000203 mixture Substances 0.000 claims abstract description 43
- 235000013305 food Nutrition 0.000 claims abstract description 19
- 239000003826 tablet Substances 0.000 claims abstract description 10
- 239000002775 capsule Substances 0.000 claims abstract description 7
- 239000008188 pellet Substances 0.000 claims abstract description 7
- 241000196324 Embryophyta Species 0.000 claims description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 235000007164 Oryza sativa Nutrition 0.000 claims description 11
- 235000009566 rice Nutrition 0.000 claims description 11
- 244000061456 Solanum tuberosum Species 0.000 claims description 10
- 235000002595 Solanum tuberosum Nutrition 0.000 claims description 10
- 241001465754 Metazoa Species 0.000 claims description 9
- 241000251468 Actinopterygii Species 0.000 claims description 5
- 240000004713 Pisum sativum Species 0.000 claims description 5
- 235000010582 Pisum sativum Nutrition 0.000 claims description 5
- 235000013601 eggs Nutrition 0.000 claims description 5
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 5
- 239000011707 mineral Substances 0.000 claims description 5
- 235000013343 vitamin Nutrition 0.000 claims description 5
- 229930003231 vitamin Natural products 0.000 claims description 5
- 239000011782 vitamin Substances 0.000 claims description 5
- 229940088594 vitamin Drugs 0.000 claims description 5
- 235000011299 Brassica oleracea var botrytis Nutrition 0.000 claims description 4
- 240000003259 Brassica oleracea var. botrytis Species 0.000 claims description 4
- 235000010469 Glycine max Nutrition 0.000 claims description 4
- 235000010755 mineral Nutrition 0.000 claims description 4
- 235000013336 milk Nutrition 0.000 claims description 3
- 239000008267 milk Substances 0.000 claims description 3
- 210000004080 milk Anatomy 0.000 claims description 3
- 235000012015 potatoes Nutrition 0.000 claims description 3
- 235000017647 Brassica oleracea var italica Nutrition 0.000 claims description 2
- 244000068988 Glycine max Species 0.000 claims description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 claims description 2
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 2
- 235000009337 Spinacia oleracea Nutrition 0.000 claims description 2
- 244000300264 Spinacia oleracea Species 0.000 claims description 2
- 235000004626 essential fatty acids Nutrition 0.000 claims description 2
- -1 fibres Substances 0.000 claims description 2
- 235000014571 nuts Nutrition 0.000 claims description 2
- 239000011573 trace mineral Substances 0.000 claims description 2
- 235000013619 trace mineral Nutrition 0.000 claims description 2
- 240000007594 Oryza sativa Species 0.000 claims 2
- 241001285484 Melitaea ala Species 0.000 claims 1
- 235000018102 proteins Nutrition 0.000 abstract description 59
- 235000016709 nutrition Nutrition 0.000 abstract description 18
- 230000035764 nutrition Effects 0.000 abstract description 17
- 241000282414 Homo sapiens Species 0.000 abstract description 15
- 235000020256 human milk Nutrition 0.000 abstract description 10
- 210000004251 human milk Anatomy 0.000 abstract description 10
- 102000014171 Milk Proteins Human genes 0.000 abstract description 2
- 108010011756 Milk Proteins Proteins 0.000 abstract description 2
- 239000013589 supplement Substances 0.000 abstract description 2
- 235000001014 amino acid Nutrition 0.000 description 43
- 229940024606 amino acid Drugs 0.000 description 43
- 208000002720 Malnutrition Diseases 0.000 description 11
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 10
- 241000209094 Oryza Species 0.000 description 10
- 239000000546 pharmaceutical excipient Substances 0.000 description 10
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 9
- 208000003286 Protein-Energy Malnutrition Diseases 0.000 description 8
- 239000008187 granular material Substances 0.000 description 8
- 235000020826 protein-energy malnutrition Nutrition 0.000 description 8
- 239000000314 lubricant Substances 0.000 description 7
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 6
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 6
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 5
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 5
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 5
- 238000007907 direct compression Methods 0.000 description 5
- 235000019197 fats Nutrition 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 235000013322 soy milk Nutrition 0.000 description 5
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 4
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 4
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 4
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 4
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- WNLRTRBMVRJNCN-UHFFFAOYSA-N adipic acid Chemical compound OC(=O)CCCCC(O)=O WNLRTRBMVRJNCN-UHFFFAOYSA-N 0.000 description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 4
- 235000019688 fish Nutrition 0.000 description 4
- 239000008101 lactose Substances 0.000 description 4
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 4
- 235000013372 meat Nutrition 0.000 description 4
- 108090000765 processed proteins & peptides Proteins 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- 108010084695 Pea Proteins Proteins 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 3
- 108010073771 Soybean Proteins Proteins 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 235000019789 appetite Nutrition 0.000 description 3
- 230000036528 appetite Effects 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 206010061428 decreased appetite Diseases 0.000 description 3
- 239000003995 emulsifying agent Substances 0.000 description 3
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 3
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 235000000824 malnutrition Nutrition 0.000 description 3
- 230000001071 malnutrition Effects 0.000 description 3
- 235000013575 mashed potatoes Nutrition 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 239000008108 microcrystalline cellulose Substances 0.000 description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 208000015380 nutritional deficiency disease Diseases 0.000 description 3
- 235000019702 pea protein Nutrition 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 102000004196 processed proteins & peptides Human genes 0.000 description 3
- 235000021134 protein-rich food Nutrition 0.000 description 3
- 229940001941 soy protein Drugs 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 2
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- 239000001361 adipic acid Substances 0.000 description 2
- 235000011037 adipic acid Nutrition 0.000 description 2
- 235000010443 alginic acid Nutrition 0.000 description 2
- 229920000615 alginic acid Polymers 0.000 description 2
- 208000022531 anorexia Diseases 0.000 description 2
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 2
- 235000013361 beverage Nutrition 0.000 description 2
- CJZGTCYPCWQAJB-UHFFFAOYSA-L calcium stearate Chemical class [Ca+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O CJZGTCYPCWQAJB-UHFFFAOYSA-L 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 235000013330 chicken meat Nutrition 0.000 description 2
- 235000015165 citric acid Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- RBLGLDWTCZMLRW-UHFFFAOYSA-K dicalcium;phosphate;dihydrate Chemical compound O.O.[Ca+2].[Ca+2].[O-]P([O-])([O-])=O RBLGLDWTCZMLRW-UHFFFAOYSA-K 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000015220 hamburgers Nutrition 0.000 description 2
- 235000015243 ice cream Nutrition 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 2
- 229960003136 leucine Drugs 0.000 description 2
- 235000019359 magnesium stearate Nutrition 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000012459 muffins Nutrition 0.000 description 2
- 230000000474 nursing effect Effects 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 230000036186 satiety Effects 0.000 description 2
- 235000019627 satiety Nutrition 0.000 description 2
- 235000019333 sodium laurylsulphate Nutrition 0.000 description 2
- 229940071440 soy protein isolate Drugs 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 235000013616 tea Nutrition 0.000 description 2
- 238000005550 wet granulation Methods 0.000 description 2
- 235000020985 whole grains Nutrition 0.000 description 2
- FRLGFEJDRMTGHL-YFKPBYRVSA-N (2s)-6-amino-2-(carboxyamino)hexanoic acid Chemical compound NCCCC[C@@H](C(O)=O)NC(O)=O FRLGFEJDRMTGHL-YFKPBYRVSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- QNAYBMKLOCPYGJ-UHFFFAOYSA-N Alanine Chemical compound CC([NH3+])C([O-])=O QNAYBMKLOCPYGJ-UHFFFAOYSA-N 0.000 description 1
- 241000981138 Allium flavum Species 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 235000019739 Dicalciumphosphate Nutrition 0.000 description 1
- 239000001856 Ethyl cellulose Substances 0.000 description 1
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 1
- 206010053172 Fatal outcomes Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 208000002705 Glucose Intolerance Diseases 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- 239000004705 High-molecular-weight polyethylene Substances 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 240000003183 Manihot esculenta Species 0.000 description 1
- 235000016735 Manihot esculenta subsp esculenta Nutrition 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000203593 Piper nigrum Species 0.000 description 1
- 235000008184 Piper nigrum Nutrition 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 241001522306 Serinus serinus Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 240000003834 Triticum spelta Species 0.000 description 1
- 235000003095 Vaccinium corymbosum Nutrition 0.000 description 1
- 240000000851 Vaccinium corymbosum Species 0.000 description 1
- 240000001717 Vaccinium macrocarpon Species 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 241000219094 Vitaceae Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000000996 additive effect Effects 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 230000002009 allergenic effect Effects 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000001539 anorectic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003963 antioxidant agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 235000006708 antioxidants Nutrition 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 235000013614 black pepper Nutrition 0.000 description 1
- 235000021014 blueberries Nutrition 0.000 description 1
- 235000021329 brown rice Nutrition 0.000 description 1
- NKWPZUCBCARRDP-UHFFFAOYSA-L calcium bicarbonate Chemical compound [Ca+2].OC([O-])=O.OC([O-])=O NKWPZUCBCARRDP-UHFFFAOYSA-L 0.000 description 1
- 229910000020 calcium bicarbonate Inorganic materials 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 239000008116 calcium stearate Substances 0.000 description 1
- 235000013539 calcium stearate Nutrition 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 239000001569 carbon dioxide Substances 0.000 description 1
- 229910002092 carbon dioxide Inorganic materials 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920003086 cellulose ether Polymers 0.000 description 1
- 150000001860 citric acid derivatives Chemical class 0.000 description 1
- 235000020965 cold beverage Nutrition 0.000 description 1
- 239000008119 colloidal silica Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 238000004040 coloring Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012937 correction Methods 0.000 description 1
- 235000012343 cottonseed oil Nutrition 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- 235000021019 cranberries Nutrition 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 239000008121 dextrose Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- NEFBYIFKOOEVPA-UHFFFAOYSA-K dicalcium phosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])([O-])=O NEFBYIFKOOEVPA-UHFFFAOYSA-K 0.000 description 1
- 229940038472 dicalcium phosphate Drugs 0.000 description 1
- 229910000390 dicalcium phosphate Inorganic materials 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 238000007908 dry granulation Methods 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 235000015897 energy drink Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 235000019325 ethyl cellulose Nutrition 0.000 description 1
- 229920001249 ethyl cellulose Polymers 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 235000013332 fish product Nutrition 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000013373 food additive Nutrition 0.000 description 1
- 239000002778 food additive Substances 0.000 description 1
- 235000013355 food flavoring agent Nutrition 0.000 description 1
- 235000015203 fruit juice Nutrition 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 235000011087 fumaric acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 229960002449 glycine Drugs 0.000 description 1
- 235000020251 goat milk Nutrition 0.000 description 1
- 235000011868 grain product Nutrition 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 235000021021 grapes Nutrition 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 210000005260 human cell Anatomy 0.000 description 1
- 239000010514 hydrogenated cottonseed oil Substances 0.000 description 1
- 239000008172 hydrogenated vegetable oil Substances 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 235000013622 meat product Nutrition 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 229920001206 natural gum Polymers 0.000 description 1
- 235000006180 nutrition needs Nutrition 0.000 description 1
- 235000020939 nutritional additive Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 238000007911 parenteral administration Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940124531 pharmaceutical excipient Drugs 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 201000009104 prediabetes syndrome Diseases 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 1
- 235000017557 sodium bicarbonate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 229960001790 sodium citrate Drugs 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000011496 sports drink Nutrition 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- XXUZFRDUEGQHOV-UHFFFAOYSA-J strontium ranelate Chemical compound [Sr+2].[Sr+2].[O-]C(=O)CN(CC([O-])=O)C=1SC(C([O-])=O)=C(CC([O-])=O)C=1C#N XXUZFRDUEGQHOV-UHFFFAOYSA-J 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000000375 suspending agent Substances 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- XOOUIPVCVHRTMJ-UHFFFAOYSA-L zinc stearate Chemical compound [Zn+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O XOOUIPVCVHRTMJ-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23C—DAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
- A23C11/00—Milk substitutes, e.g. coffee whitener compositions
- A23C11/02—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins
- A23C11/10—Milk substitutes, e.g. coffee whitener compositions containing at least one non-milk component as source of fats or proteins containing or not lactose but no other milk components as source of fats, carbohydrates or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L11/00—Pulses, i.e. fruits of leguminous plants, for production of food; Products from legumes; Preparation or treatment thereof
- A23L11/60—Drinks from legumes, e.g. lupine drinks
- A23L11/65—Soy drinks
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L13/00—Meat products; Meat meal; Preparation or treatment thereof
- A23L13/50—Poultry products, e.g. poultry sausages
- A23L13/52—Comminuted, emulsified or processed products; Pastes; Reformed or compressed products from poultry meat
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/185—Vegetable proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Definitions
- the invention relates to a powder, such as an amino acid and/or protein powder that is optimized for human beings in the respect that its combined amino acid profile reflects the amino acid profile of human mother's milk protein.
- the invented powder such as an amino acid and/or protein powder is suitable to be used as a nutrition supplement and relates also to tablets, capsules or pellets comprising said protein mixture, as well as food products comprising said protein mixture.
- Food is defined as protein, fat and carbohydrates.
- Protein rich food such as meat, egg, milk and fish
- carbohydrate rich food such as vegetables, potatoes, rice, etc.
- Protein from animal sources are typically more full worthy, i.e. have a higher biological activity, than protein from vegetable sources.
- PEM Protein-energy malnutrition
- EP0312612 discloses a nutritive emulsion comprising 4-15 % by weight of amino acids as well as 3 to 12 % by weight of lipids and 71,5 to 93 % by weight of water as well as 3 % of an emulsifier.
- EP0399656 discloses the use of peptides in the manufacturing of a nutrient composition for the supplementation of cysteins.
- the document also discloses a heat sterilised nutrient composition being a solution or in a jelly form.
- compositions that contains free amino acids It has however been shown that compositions that solely contains free amino acids will not be optimal for a human being and the optimal nutrition powder needs to contain as much as possible of proteins and less free amino acids. However, for parenteral administration are free amino acids commonly used.
- US 2007/0225348 disclose low calorie beverages containing water.
- the beverages contains high amount of isoleucine and are supposed to be used to treat humans suffering from diabetes or impaired glucose tolerance. For obvious reasons it is not likely to industrialize the production of protein concentrate from real human mother's milk.
- a powder such as an amino acid and/or protein powder that is similar to the protein of human mother's milk.
- the invented protein mixture is optimal for the treatment of the above mentioned problems associated with protein-energy malnutrition.
- the present invention relates to a powder, such as an amino acid and/or protein powder with a combined amino acid profile, being optimal for humans by reflecting the amino acid profile of mother's milk.
- Human mother's milk is designed by nature to supply optimally composed nutrition, protect against infections and stimulate growth. As such it is defined as the the optimal protein source for a human beings, developed and improved by years and years of evolution.
- amino acid profile of mother's milk based on analysis from both the National Agricultural Library in USA (www.nal.usda.
- the invented nutrition formula has been given the following amino acid profile: He in an amount of 45-60 mg/g, Leu in an amount of 90-105 mg/g, Lys in an amount of 60-75 mg/g, Met in an amount of 10-25 mg/g, Phe in an amount of 35-55 mg/g, VaI in an amount of 50- 65 mg/g, Tre in an amount of 40-50 mg/g, Trp in an amount of 15-25 mg/g, His in an amount of 20-30 mg/g, Cy s in an amount of 15-30 mg/g, Tyr in an amount of 35- 55 mg/g, Arg in an amount of 30-80 mg/g, Ala in an amount of 35-50 mg/g, Asp in an amount of 80-115 mg/g, GIn in an amount of 165-195 mg/g, GIy in an amount of 20-45 mg/g, Pro in an amount of 80-100 mg/g and Ser in an amount of 40-55 mg/g.
- the invented powder such as an amino acid and/or protein powder contains all the amino acids that a human being needs, designed in the specific relationship as decided by years and years of evolution.
- the powder can easily be mixed with for example mashed potatoes in order to increase the protein content and then given to a person who lacks appetite, but who agrees to eat a little of this , easily digested food rather than for example meat or fish (see p.1 ;35).
- the nutrition powder is easy to store and may be stored for long period and easy to transport to different parts of the world due to that the powder is substantially free from water.
- the invention also relates to capsules, tablets and pellets comprising said powder as well as food products comprising said .
- amino acid names and atom names are used as defined by the Protein DataBank (PNB) (www.pdb.org), which is based on the IUPAC nomenclature (IUPAC Nomenclature and Symbolism for Amino Acids and Peptides (residue names, atom names etc.), Eur J Biochem., 138, 9-37 (1984) together with their corrections in Eur J Biochem., 152, 1 (1985).
- PDB Protein DataBank
- amino acid is intended to indicate an amino acid from the group consisting of alanine (Ala or A), cysteinee (Cys or C), aspartic acid (Asp or D), glutamic acid (GIu or E), phenylalanine (Phe or F), glycine (GIy or G), histidine (His or H), isoleucine (He or I), lysine (Lys or K), leucine (Leu or L), methionine (Met or M), asparagine (Asn or N), proline (Pro or P), glutamine (GIn or Q), arginine (Arg or R), serine (Ser or S), threonine (Thr or T), valine (VaI or V), tryptophan (Trp or W) and tyrosine (Tyr or Y).
- the invention relates to a powder, such as an amino acid and/or protein powder having a specific amino acid profile, being optimal for human beings and which in a way reflects the amino acid profile of mother's milk.
- a powder such as an amino acid and/or protein powder having a specific amino acid profile
- the nutrition powder of the invention may be added to mashed potatoes, ice cream, meat balls as well as cakes, or whatever the consumer wish to consume.
- the invented powder may also be useful in conventional food products as well as used to improve food products in hospitals, schools, nursing homes, prisons, elderly homes as well as private homes.
- the invention relates to a powder having the amino acid profile (all amounts are in mg/g protein); lie in an amount of 45-60 mg/g, such as about 50-58 or 46-50 mg/g, Leu in an amount of 90-105 mg/g, such as 90-95 mg/g, Lys in an amount of 60-75 mg/g, such as 64-70 mg/g, Met in an amount of 10-25 mg/g, such as 14-20 mg/g, Phe in an amount of 35-55 mg/g, such as 30-50 mg/g, VaI in an amount of 50-65 mg/g, such as 50-57 mg/g, Thr in an amount of 40-50 mg/g, such as 40-45 mg/g, Trp in an amount of 15-25 mg/g, such as 15-18 mg/g, His in an amount of 20-30 mg/g, such as 26-29 mg/g, Cys in an amount of 15-30 mg/g, such as 15-20 mg/g, Tyr in an amount of 35-55 mg/g, such as 42-48 mg/
- the powder may be obtained from one or more sources and may comprise a mixture of amino acid isolates and/or protein sources or isolates.
- the powder may be from both plants and/or animal sources, which sources depends on what and who should use the powder. In areas were there is a lack of animal sources it may be preferred to use plant sources. This also applies when the powder will be consumed by vegetarian people or people who prefer plants sources.
- the powder may also be a mixture of different sources, such as a mixture of at least two, three, four or more different plant sources. One specific example is when the powder is obtained from four different plant sources.
- the powder of the invention comprises at least 60 w/w % protein, such as 65, 70, 75, 80, 85, 90 or even 95 w/w % protein.
- the amount of protein will be dependent on were the product will be consumed, i.e., different demands from different populations as well as different regulations.
- the powder comprises substantially intact proteins, which the consumer upon intake will degrade into peptide pieces and amino acids which are of importance for the consumer. Additionally, the powder will in certain embodiments contain a low amount of fat, such as less than 10, 9, 8, 7, 6, 5, 4, 3, 2 % fat or even be substantially free from fat. The fat being obtained from the different protein sources, which are not healthy to consume and which there is no need to intake.
- the powder of the invention may contain powder obtained from one or more different sources as well as being a mixture of proteins and amino acids as well as peptides from proteins.
- the powder may be obtained from both animal as plant sources, such as fish, egg and milk from the animal sources. For example may both goat and cow milk be used.
- plant sources includes spinaches, nuts, cauliflowers, broccolis, potatoes, rice, beans, and peas.
- any source may be used as long as the above defined amino acid profile is obtained and maintained.
- Additional components may be added to the nutrition powder to improve the nutritional value, such as for example trace elements, minerals, vitamins, fibres and essential fatty acids.
- vitamins such as vitamin A, B, E and K.
- minerals and omega fatty acids such as polyunsaturated fatty acids.
- the invented powder such as an amino acid and/or protein powder is substantially free from heavy metals as well as antibiotics and water.
- Another name of the powder may be a nutrition powder.
- Table 1 below show two examples of the amino acid profile in mother's milk.
- Prolin 80 100 20 80 80
- composition may be in the form of a tablet depending on the user and the use.
- tablets containing various excipients such as microcrystalline cellulose, sodium citrate, calcium carbonate, dicalcium phosphate and glycine may be employed along with various disintegrants such as starch (and preferably corn, potato or tapioca starch), alginic acid and certain complex silicates, together with granulation binders like polyvinylpyrrolidone, sucrose, gelatin and acacia.
- disintegrants such as starch (and preferably corn, potato or tapioca starch), alginic acid and certain complex silicates, together with granulation binders like polyvinylpyrrolidone, sucrose, gelatin and acacia.
- lubricating agents such as magnesium stearate, sodium lauryl sulfate and talc are often very useful for tabletting purposes.
- compositions of a similar type may also be employed as fillers in gelatin capsules; preferred materials in this connection also include lactose or milk sugar as well as high molecular weight polyethylene glycols.
- preferred materials in this connection also include lactose or milk sugar as well as high molecular weight polyethylene glycols.
- the active ingredient may be combined with various sweetening or flavouring agents, colouring matter or dyes, and, if so desired, emulsifying and/or suspending agents as well, together with such diluents as water, ethanol, propylene glycol, glycerine and various like combinations thereof.
- a composition for tableting or capsule filling may be prepared by wet granulation.
- wet granulation some or all of the active ingredients and excipients in powder form are blended and then further mixed in the presence of a liquid, typically water, which causes the powders to clump into granules.
- the granulates are screened and/or milled, dried and then screened and/or milled to the desired particle size.
- the granulates may be tableted, or other excipients may be added prior to tableting, such as a glidant and/or a lubricant.
- a tableting composition may be prepared conventionally by dry blending.
- the blended composition of the actives and excipients may be compacted into a slug or a sheet and then comminuted into compacted granules. The compacted granules may subsequently be compressed into a tablet.
- a blended composition may be compressed directly into a compacted dosage form using direct compression techniques.
- Direct compression produces a more uniform tablet without granules.
- Excipients that are particularly well suited for direct compression tableting include microcrystalline cellulose, spray dried lactose, dicalcium phosphate dihydrate and colloidal silica. The proper use of these and other excipients in direct compression tableting is known to those in the art with experience and skill in particular composition challenges of direct compression tableting.
- a capsule filling of the present invention may comprise any of the aforementioned blends and granulates that were described with reference to tableting, however, they are not subjected to a final tableting step.
- Effervescence is the reaction (in water) of acids and bases producing carbon dioxide.
- the proportion of acids may be varied, as long as the bicarbonate is completely neutralised.
- acids used in this reaction are citric acid, tartaric acid, malic acid, fumaric acid, adipic acid, acid citrates, succinic acid and mixtures thereof.
- Citric acid is the most commonly used, and it imparts a citrus-like taste to the product.
- bases used in the effervescent reaction are sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, calcium bicarbonate, magnesium carbonate, sodium glycocarbonate, carboxylysine and mixtures thereof.
- Sodium bicarbonate is very common in effervescent formulas.
- compositions may comprise at least one additive selected from the group comprising excipients, lubricants, emulgators, fillers, surfactants (e.g., polysorbate 80 and sodium lauryl sulfate), flavours and colours, including natural or synthetic ones, vitamins, sweeteners (acesulfame potassium, sodium saccharin, aspartame, and surcalose), nutritional additives (e.g antioxidants), and mixtures thereof.
- Substances giving taste, colour or antioxidative properties to the composition can be plant polyphenols (Cheynier V. Am J Clin Nutr. 2005; 81 : 223- 229) coming from natural sources such as blueberries, cranberries, grapes and tea leaves.
- the composition may include one or more excipient, such as a pharmaceutical excipient or a food additive.
- excipients include, e.g., starches, natural gums, cellulose gums, microcrystalline cellulose, methylcellulose, cellulose ethers, sodium carboxymethylcellulose, ethylcellulose, gelatin, dextrose, lactose, sucrose, sorbitol, mannitol, polyethylene glycol, polyvinylpyrrolidone, pectins, alginates, polyacrylamides, polyvinyloxoazolidone, polyvinylalcohols and mixtures thereof.
- composition may contain various lubricants suitable for use in the composition including water dispersible, water soluble, water insoluble lubricants and combinations thereof.
- water soluble lubricants include sodium benzoate, polyethylene glycol, L-leucine, adipic acid, and combinations thereof.
- the composition may also include water insoluble lubricants including, e.g., stearates (e.g., magnesium stearate, calcium stearate and zinc stearate), oils (e.g., mineral oil, hydrogenated and partially hydrogenated vegetable oils, and cotton seed oil) and combinations thereof.
- stearates e.g., magnesium stearate, calcium stearate and zinc stearate
- oils e.g., mineral oil, hydrogenated and partially hydrogenated vegetable oils, and cotton seed oil
- the effervescent part may also comprise vitamins, and minerals as disclosed in U.S. Pat. No. 4,725,427 "Effervescent vitamin-mineral granule preparation". Effervescent energy tablet dissolving in any cold beverage (fruit juice, sports drinks, iced teas, sodas, etc.) to create an instant energy drink are commercially availed and such compositions may also be formulated according to the invention containing our invented composition.
- the nutrition powder may also be pellets. Pellets may be advantage if the protein composition will be transported over long distances or stored for a longer period in sachets such as those sachets that are used for conventional animal food products. The pellets may also be made in the same manner as conventional animal food products are produced using the same kind of equipment.
- the invention also relates to food products comprising said powder.
- Powder from rice was purchased from RICE PROTEIN TECHNOLOGIES LLC under the trademark NovaProTM70, being a Rice protein concentrate from brown rice.
- a Soy Protein Isolate powder was purchased from REMY INDUSTRIES under the trademark Remypro N80+.
- a Pea Protein Isolate was purchased from COSUCRA GROUP under the trademark Pisane®.
- Purified Potato Protein was purchased from Solanic B. V under the trademark Beverich 303P.
- the protein sources were mixed in the following relationship: 43,2% pea protein, 25,9% potato protein, 12,9% rice protein and 12,9% soy protein.
- the amino acids added were in the following relationship: Prolin (3,3%), Leucin (0,7%), Tryptophan (0,6%), Cystein (0,3%) and Glutamin (0,2%). The total protein content of the mixture was >80%.
- Example 2 By combining pea, potato and rice protein using the same trademarks as stated in example 1 , and by adding Prolin, Leucin, Tryptophan and Cystein, a soy free vegetarian based powder with a combined amino acid profile within the given ranges was obtained.
- the protein sources were mixed in the following relationship: 49,4% pea protein, 24,7% rice protein and 20,6% potato protein.
- the amino acids added were: Prolin (3,4%), Leucin (0,8%), Tryptophan (0,7%) and Cystein (0,4%).
- the total protein content of the mixture was >85%.
- example 3 the relationship from example 1 was used to create a ready-to-drink protein drink based on Alpro soy milk.
- Remypro N80+ soy protein isolate containing 79% protein
- soy protein in Alpro Soy milk 3,7 g/100 ml
- 87,1 g of powder mix (excluding the 12,9 g of soy protein) was mixed in 275 ml of Alpro Soy milk.
- the powder prepared under example 1 was used to prepare chicken burgers by a mixture of the following ingredients: 100 g nutrition powder, 50O g minced chicken meat, yellow onion, garlic, eggs, soy milk, salt, black pepper, ginger, vegetable boullion, cooked whole grain Dinkel. The mixture was formed as burgers and fried in a pan. In a test, this product received high scores on taste, structure and satiety.
- Example 5 The powder soy drink prepared under example 3 was used to bake muffins using a mix of the following ingredients: 250 g whole grain flour, 87,1 g Nutrition Powder, 3 g salt, 5 g Baking Powder, 100 g rapeseed oil, 150 g Raw Sugar, 275 ml Alpro Soy Milk, 50 g eggs. The muffins were baked in an oven, 175°C for 15 minutes. Again, the product scored high on taste and satiety.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Mycology (AREA)
- Botany (AREA)
- Agronomy & Crop Science (AREA)
- Molecular Biology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The invention relates to a powder, such as an amino acid and/or protein powder that is optimized for human beings in the respect that its combined amino acid profile reflects the amino acid profile of human mother's milk protein. The invented powder, such as an amino acid and/or protein powder is suitable to be used as a nutrition supplement and relates also to tablets, capsules or pellets comprising said protein mixture, as well as food products comprising said protein mixture.
Description
Nutritional supplement with specific amino acid profile
FIELD OF INVENTION
The invention relates to a powder, such as an amino acid and/or protein powder that is optimized for human beings in the respect that its combined amino acid profile reflects the amino acid profile of human mother's milk protein. The invented powder, such as an amino acid and/or protein powder is suitable to be used as a nutrition supplement and relates also to tablets, capsules or pellets comprising said protein mixture, as well as food products comprising said protein mixture.
BACKGROUND OF INVENTION
Food is defined as protein, fat and carbohydrates. However, protein is the most dominant ingredient (proteios, primary from Greek protos = first). Protein makes up about 70% of the dry weight of human cells, and the human body produces up to 300 billion new cells every 24 hours. The intake of full worthy protein, i.e. the cornerstones of cell renewal, is therefore highly important for humans in order to stay healthy.
Protein rich food, such as meat, egg, milk and fish, is often more expensive than carbohydrate rich food such as vegetables, potatoes, rice, etc. Protein from animal sources are typically more full worthy, i.e. have a higher biological activity, than protein from vegetable sources.
Today many people are suffering from malnutrition in various ways and for various reasons. Protein-energy malnutrition (PEM) is a potentially fatal disorder that develops in children and adults whose consumption of protein and energy is insufficient to satisfy the body's nutritional needs. Severe PEM is the leading cause of death in children in developing countries. In the industrialized world, fatal outcomes due to PEM mainly occurs in connection with complicated diseases such as for example cancer and COPD, while mild to moderate PEM is very common among patients in healthcare centres, nursing homes and among the elderly. PEM often leads to a worsened patient condition, prolonged rehabilitation, increased waiting lists and increased medical costs.
It is common that many old people loose their appetite and start to eat less, loose weight and become more passive. In this weakened condition it is usually more difficult to eat protein rich foods such as meat or fish. Instead many eat only more easily digested food, such as for example mashed potatoes, which are typically rich in carbohydrates and low in protein content. The same may apply for people who suffer from anorexia, as well as many vegetarians who solely base their nutrition on vegetarian food.
There is no easy or generally established way to solve the problems related to the various causes of malnutrition. Breastfeeding a baby for at least six months is considered the best way to prevent early-childhood malnutrition, while tube feeding or intravenous feeding is typically used to supply nutrition to patients who can not or will not eat protein-rich foods.
EP0312612 discloses a nutritive emulsion comprising 4-15 % by weight of amino acids as well as 3 to 12 % by weight of lipids and 71,5 to 93 % by weight of water as well as 3 % of an emulsifier.
EP0399656 discloses the use of peptides in the manufacturing of a nutrient composition for the supplementation of cysteins. The document also discloses a heat sterilised nutrient composition being a solution or in a jelly form.
US 2007/0286909 disclose composition that contains free amino acids. It has however been shown that compositions that solely contains free amino acids will not be optimal for a human being and the optimal nutrition powder needs to contain as much as possible of proteins and less free amino acids. However, for parenteral administration are free amino acids commonly used.
US 2007/0225348 disclose low calorie beverages containing water. The beverages contains high amount of isoleucine and are supposed to be used to treat humans suffering from diabetes or impaired glucose tolerance. For obvious reasons it is not likely to industrialize the production of protein concentrate from real human mother's milk. However, by analyzing the amino acid content relationship in protein from human mother's milk, and then create a protein mixture based on industrially available protein sources that reflects this amino acid content relationship, it is for the first time possible to create a powder, such as an amino acid and/or protein powder that is similar to the protein of human mother's milk.
The invented protein mixture is optimal for the treatment of the above mentioned problems associated with protein-energy malnutrition.
SUMMARY OF THE INVENTION
The present invention relates to a powder, such as an amino acid and/or protein powder with a combined amino acid profile, being optimal for humans by reflecting the amino acid profile of mother's milk. Human mother's milk is designed by nature to supply optimally composed nutrition, protect against infections and stimulate growth. As such it is defined as the the optimal protein source for a human beings, developed and improved by years and years of evolution.
By reflecting the amino acid profile of mother's milk, based on analysis from both the National Agricultural Library in USA (www.nal.usda. gov) and the Swedish National Food Administration (www.slv.se), the invented nutrition formula has been given the following amino acid profile: He in an amount of 45-60 mg/g, Leu in an amount of 90-105 mg/g, Lys in an amount of 60-75 mg/g, Met in an amount of 10-25 mg/g, Phe in an amount of 35-55 mg/g, VaI in an amount of 50- 65 mg/g, Tre in an amount of 40-50 mg/g, Trp in an amount of 15-25 mg/g, His in an amount of 20-30 mg/g, Cy s in an amount of 15-30 mg/g, Tyr in an amount of 35- 55 mg/g, Arg in an amount of 30-80 mg/g, Ala in an amount of 35-50 mg/g, Asp in an amount of 80-115 mg/g, GIn in an amount of 165-195 mg/g, GIy in an amount of 20-45 mg/g, Pro in an amount of 80-100 mg/g and Ser in an amount of 40-55 mg/g.
The invented powder, such as an amino acid and/or protein powder contains all the amino acids that a human being needs, designed in the specific relationship as decided by years and years of evolution. The powder can easily be mixed with for example mashed potatoes in order to increase the protein content and then given to a person who lacks appetite, but who agrees to eat a little of this , easily digested food rather than for example meat or fish (see p.1 ;35).
Many institutions that treat patients with anorexia are today forced to use nutrition drinks that are available on the market, many of which are not always very good tasting. By providing the invented powder in a shape and taste that the anorectic patient approves , i.e. any kind of food product that the person likes, allows the treating institution to supply the patient with essential amino acids and/or proteins.
Additionally, the nutrition powder is easy to store and may be stored for long period and easy to transport to different parts of the world due to that the powder is substantially free from water.
The invention also relates to capsules, tablets and pellets comprising said powder as well as food products comprising said .
DETAILED DESCRIPTION OF THE INVENTION
Definitions
In the present context, amino acid names and atom names are used as defined by the Protein DataBank (PNB) (www.pdb.org), which is based on the IUPAC nomenclature (IUPAC Nomenclature and Symbolism for Amino Acids and Peptides (residue names, atom names etc.), Eur J Biochem., 138, 9-37 (1984) together with their corrections in Eur J Biochem., 152, 1 (1985). The term "amino acid" is intended to indicate an amino acid from the group consisting of alanine (Ala or A), cysteinee (Cys or C), aspartic acid (Asp or D), glutamic acid (GIu or E),
phenylalanine (Phe or F), glycine (GIy or G), histidine (His or H), isoleucine (He or I), lysine (Lys or K), leucine (Leu or L), methionine (Met or M), asparagine (Asn or N), proline (Pro or P), glutamine (GIn or Q), arginine (Arg or R), serine (Ser or S), threonine (Thr or T), valine (VaI or V), tryptophan (Trp or W) and tyrosine (Tyr or Y).
Invention
The invention relates to a powder, such as an amino acid and/or protein powder having a specific amino acid profile, being optimal for human beings and which in a way reflects the amino acid profile of mother's milk. By the development of such a powder it is for the first time possible to prepare food products having a perfect nutrition value. Thereby it is for the first time possible to provide improved interesting food products to people lacking appetite. For example, the nutrition powder of the invention may be added to mashed potatoes, ice cream, meat balls as well as cakes, or whatever the consumer wish to consume. Thereby some of the problems associated with protein-energy malnutrition can be addressed in new ways. The invented powder may also be useful in conventional food products as well as used to improve food products in hospitals, schools, nursing homes, prisons, elderly homes as well as private homes. In one embodiment the invention relates to a powder having the amino acid profile (all amounts are in mg/g protein); lie in an amount of 45-60 mg/g, such as about 50-58 or 46-50 mg/g, Leu in an amount of 90-105 mg/g, such as 90-95 mg/g, Lys in an amount of 60-75 mg/g, such as 64-70 mg/g, Met in an amount of 10-25 mg/g, such as 14-20 mg/g, Phe in an amount of 35-55 mg/g, such as 30-50 mg/g, VaI in an amount of 50-65 mg/g, such as 50-57 mg/g, Thr in an amount of 40-50 mg/g, such as 40-45 mg/g, Trp in an amount of 15-25 mg/g, such as 15-18 mg/g, His in an amount of 20-30 mg/g, such as 26-29 mg/g, Cys in an amount of 15-30 mg/g, such as 15-20 mg/g, Tyr in an amount of 35-55 mg/g, such as 42-48 mg/g, Arg in an amount of 30-80 mg/g, such as 70-80 mg/g, Ala in an amount of 35-50 mg/g such as 45-50 mg/g, Asp in an amount of 80-115 mg/g, such as 100-112 mg/g, GIn in an amount of 165-195 mg/g, such as 165-170 mg/g, GIy in an amount of 20-45 mg/g, such as 40-45 mg/g, Pro in an amount of 80-100 mg/g such as 80-90 mg/g and Ser in an amount of 40-55 mg/g, such as 50-55 mg/g. When the powder is a mixture of amino acids the amounts need to be recalculated using the relationship between the protein and the amino acid content. Such calculation being well-known for a person skilled in the art.
The powder may be obtained from one or more sources and may comprise a mixture of amino acid isolates and/or protein sources or isolates. For certain purposes the proteins are preferred due to that the proteins are more natural
and the human being then needs to degrade the proteins by themselves which also for certain purposes improves the amino acid profile that a specific human being needs. The powder may be from both plants and/or animal sources, which sources depends on what and who should use the powder. In areas were there is a lack of animal sources it may be preferred to use plant sources. This also applies when the powder will be consumed by vegetarian people or people who prefer plants sources. The powder may also be a mixture of different sources, such as a mixture of at least two, three, four or more different plant sources. One specific example is when the powder is obtained from four different plant sources. By the use of proteins from plants, it is possible to prepare a powder which is free from casein as well as lactose and people being allergenic against those compounds can digest the powder without any risk.
In another embodiment the powder of the invention comprises at least 60 w/w % protein, such as 65, 70, 75, 80, 85, 90 or even 95 w/w % protein. The amount of protein will be dependent on were the product will be consumed, i.e., different demands from different populations as well as different regulations.
In even another embodiment the powder comprises substantially intact proteins, which the consumer upon intake will degrade into peptide pieces and amino acids which are of importance for the consumer. Additionally, the powder will in certain embodiments contain a low amount of fat, such as less than 10, 9, 8, 7, 6, 5, 4, 3, 2 % fat or even be substantially free from fat. The fat being obtained from the different protein sources, which are not healthy to consume and which there is no need to intake.
The powder of the invention may contain powder obtained from one or more different sources as well as being a mixture of proteins and amino acids as well as peptides from proteins. The powder may be obtained from both animal as plant sources, such as fish, egg and milk from the animal sources. For example may both goat and cow milk be used. Examples of plant sources, includes spinaches, nuts, cauliflowers, broccolis, potatoes, rice, beans, and peas. One example is a powder comprising proteins from rice (oryza), potato, soybean and pea. However, any source may be used as long as the above defined amino acid profile is obtained and maintained.
Additional components may be added to the nutrition powder to improve the nutritional value, such as for example trace elements, minerals, vitamins, fibres and essential fatty acids. Examples are vitamins such as vitamin A, B, E and K. Other examples are minerals and omega fatty acids such as polyunsaturated fatty acids.
Accordingly the invented powder, such as an amino acid and/or protein powder is substantially free from heavy metals as well as antibiotics and water. Another name of the powder may be a nutrition powder.
Table 1 below show two examples of the amino acid profile in mother's milk.
Min Max Dev Ex 01 Ex 02
Isoleusin* 45 60 15 48 48
Leucin* 90 105 15 90 92
Lysin* 60 75 15 68 66
Metionin* 10 25 15 15 18
Fenylalan* 35 55 20 54 54
Valin* 50 65 15 59 60
Treonin* 40 50 10 40 40
Tryptofan* 15 25 10 16 17
Histidin 20 30 10 28 29
Cystein 15 30 15 17 18
Tyrosin 35 55 20 44 45
Arginin 30 80 50 74 77
Alanin 35 50 15 48 50
Asparginsyra 80 115 35 110 107
Glutaminsyra 165 195 30 166 167
Glycin 20 45 25 44 44
Prolin 80 100 20 80 80
Serin 40 55 15 52 51
865 1215 350 Ex 01 and Ex 02 being two examples.
Tablets or capsules containing the powde.r
The above, mentioned composition may be in the form of a tablet depending on the user and the use. For oral administration, tablets containing various excipients such as microcrystalline cellulose, sodium citrate, calcium carbonate, dicalcium phosphate and glycine may be employed along with various disintegrants such as starch (and preferably corn, potato or tapioca starch), alginic acid and certain complex silicates, together with granulation binders like polyvinylpyrrolidone, sucrose, gelatin and acacia. Additionally, lubricating agents such as magnesium stearate, sodium lauryl sulfate and talc are often very useful for tabletting purposes. Solid compositions of a similar type may also be employed as fillers in gelatin capsules; preferred materials in this connection also include lactose or milk sugar as well as high molecular
weight polyethylene glycols. When aqueous suspensions and/or elixirs are desired for oral administration, the active ingredient may be combined with various sweetening or flavouring agents, colouring matter or dyes, and, if so desired, emulsifying and/or suspending agents as well, together with such diluents as water, ethanol, propylene glycol, glycerine and various like combinations thereof.
A composition for tableting or capsule filling may be prepared by wet granulation. In wet granulation, some or all of the active ingredients and excipients in powder form are blended and then further mixed in the presence of a liquid, typically water, which causes the powders to clump into granules. The granulates are screened and/or milled, dried and then screened and/or milled to the desired particle size. The granulates may be tableted, or other excipients may be added prior to tableting, such as a glidant and/or a lubricant.
A tableting composition may be prepared conventionally by dry blending. For example, the blended composition of the actives and excipients may be compacted into a slug or a sheet and then comminuted into compacted granules. The compacted granules may subsequently be compressed into a tablet.
As an alternative to dry granulation, a blended composition may be compressed directly into a compacted dosage form using direct compression techniques. Direct compression produces a more uniform tablet without granules. Excipients that are particularly well suited for direct compression tableting include microcrystalline cellulose, spray dried lactose, dicalcium phosphate dihydrate and colloidal silica. The proper use of these and other excipients in direct compression tableting is known to those in the art with experience and skill in particular composition challenges of direct compression tableting. A capsule filling of the present invention may comprise any of the aforementioned blends and granulates that were described with reference to tableting, however, they are not subjected to a final tableting step.
Effervescence is the reaction (in water) of acids and bases producing carbon dioxide. The proportion of acids may be varied, as long as the bicarbonate is completely neutralised.
Examples of acids used in this reaction are citric acid, tartaric acid, malic acid, fumaric acid, adipic acid, acid citrates, succinic acid and mixtures thereof. Citric acid is the most commonly used, and it imparts a citrus-like taste to the product. Examples of bases used in the effervescent reaction are sodium carbonate, potassium carbonate, sodium bicarbonate, potassium bicarbonate, calcium bicarbonate, magnesium carbonate, sodium glycocarbonate, carboxylysine and mixtures thereof. Sodium bicarbonate is very common in effervescent formulas.
The above mentioned composition may comprise at least one additive selected from the group comprising excipients, lubricants, emulgators, fillers,
surfactants (e.g., polysorbate 80 and sodium lauryl sulfate), flavours and colours, including natural or synthetic ones, vitamins, sweeteners (acesulfame potassium, sodium saccharin, aspartame, and surcalose), nutritional additives (e.g antioxidants), and mixtures thereof. Substances giving taste, colour or antioxidative properties to the composition can be plant polyphenols (Cheynier V. Am J Clin Nutr. 2005; 81 : 223- 229) coming from natural sources such as blueberries, cranberries, grapes and tea leaves.
The composition may include one or more excipient, such as a pharmaceutical excipient or a food additive. Examples of suitable excipients include, e.g., starches, natural gums, cellulose gums, microcrystalline cellulose, methylcellulose, cellulose ethers, sodium carboxymethylcellulose, ethylcellulose, gelatin, dextrose, lactose, sucrose, sorbitol, mannitol, polyethylene glycol, polyvinylpyrrolidone, pectins, alginates, polyacrylamides, polyvinyloxoazolidone, polyvinylalcohols and mixtures thereof.
Additionally the composition may contain various lubricants suitable for use in the composition including water dispersible, water soluble, water insoluble lubricants and combinations thereof. Examples of useful water soluble lubricants include sodium benzoate, polyethylene glycol, L-leucine, adipic acid, and combinations thereof.
The composition may also include water insoluble lubricants including, e.g., stearates (e.g., magnesium stearate, calcium stearate and zinc stearate), oils (e.g., mineral oil, hydrogenated and partially hydrogenated vegetable oils, and cotton seed oil) and combinations thereof. The effervescent part may also comprise vitamins, and minerals as disclosed in U.S. Pat. No. 4,725,427 "Effervescent vitamin-mineral granule preparation". Effervescent energy tablet dissolving in any cold beverage (fruit juice, sports drinks, iced teas, sodas, etc.) to create an instant energy drink are commercially availed and such compositions may also be formulated according to the invention containing our invented composition. The nutrition powder may also be pellets. Pellets may be advantage if the protein composition will be transported over long distances or stored for a longer period in sachets such as those sachets that are used for conventional animal food products. The pellets may also be made in the same manner as conventional animal food products are produced using the same kind of equipment. The invention also relates to food products comprising said powder.
Examples of different food products include ice cream, cakes, different meat products, fish products, cereal products as well as different drink products.
EXAMPLES
Example 1
Powder from rice was purchased from RICE PROTEIN TECHNOLOGIES LLC under the trademark NovaPro™70, being a Rice protein concentrate from brown rice. A Soy Protein Isolate powder was purchased from REMY INDUSTRIES under the trademark Remypro N80+. A Pea Protein Isolate was purchased from COSUCRA GROUP under the trademark Pisane®. Purified Potato Protein was purchased from Solanic B. V under the trademark Beverich 303P. By mixing these four different powder sources in a specific relationship, and by adding small amounts of amino acid isolates as purchased from Scandinavian Nutrients AB (Gothenburg, Sweden), a nutrition powder mixture with a combined amino acid profile within the given ranges was obtained. The protein sources were mixed in the following relationship: 43,2% pea protein, 25,9% potato protein, 12,9% rice protein and 12,9% soy protein. The amino acids added were in the following relationship: Prolin (3,3%), Leucin (0,7%), Tryptophan (0,6%), Cystein (0,3%) and Glutamin (0,2%). The total protein content of the mixture was >80%.
Example 2 By combining pea, potato and rice protein using the same trademarks as stated in example 1 , and by adding Prolin, Leucin, Tryptophan and Cystein, a soy free vegetarian based powder with a combined amino acid profile within the given ranges was obtained. The protein sources were mixed in the following relationship: 49,4% pea protein, 24,7% rice protein and 20,6% potato protein. The amino acids added were: Prolin (3,4%), Leucin (0,8%), Tryptophan (0,7%) and Cystein (0,4%). The total protein content of the mixture was >85%.
Example 3
In example 3 the relationship from example 1 was used to create a ready-to-drink protein drink based on Alpro soy milk. However, by replacing the 12,9% of Remypro N80+ soy protein isolate (containing 79% protein) with the natural content of soy protein in Alpro Soy milk (3,7 g/100 ml), a protein rich drink with the amino acid profile within the given ranges was obtained. In this example 87,1 g of powder mix (excluding the 12,9 g of soy protein) was mixed in 275 ml of Alpro Soy milk.
Example 4
The powder prepared under example 1 was used to prepare chicken burgers by a mixture of the following ingredients: 100 g nutrition powder, 50O g minced chicken meat, yellow onion, garlic, eggs, soy milk, salt, black pepper, ginger, vegetable boullion, cooked whole grain Dinkel. The mixture was formed as burgers and fried in a pan. In a test, this product received high scores on taste, structure and satiety.
Example 5 The powder soy drink prepared under example 3 was used to bake muffins using a mix of the following ingredients: 250 g whole grain flour, 87,1 g Nutrition Powder, 3 g salt, 5 g Baking Powder, 100 g rapeseed oil, 150 g Raw Sugar, 275 ml Alpro Soy Milk, 50 g eggs. The muffins were baked in an oven, 175°C for 15 minutes. Again, the product scored high on taste and satiety.
Claims
1. A powder, being substantially free from water and having the amino acid profile; a. He in an amount of 45-60 mg/g, b. Leu in an amount of 90- 105 mg/g c. Lys in an amount of 60-75 mg/g d. Met in an amount of 10-25 mg/g e. Phe in an amount of 35-55 mg/g f. VaI in an amount of 50-65 mg/g g. Tre in an amount of 40-50 mg/g h. Trp in an amount of 15-25 mg/g i. His in an amount of 20-30 mg/g j. Cy s in an amount of 15-30 mg/g k. Tyr in an amount of 35-55 mg/g
1. Arg in an amount of 30-80 mg/g m. Ala in an amount of 35-50 mg/g n. Asp in an amount of 80-115 mg/g o. GIn in an amount of 165-195 mg/g p. GIy in an amount of 20-45 mg/g q. Pro in an amount of 80-100 mg/g and r. Ser in an amount of 40-55 mg/g
2. The powder according to claims 1, wherein said powder is a mixture of amino acids and/or proteins.
3. The powder according to claims 1-2, wherein said proteins are derived from plant and/or animal sources.
4. The powder according to any of preceding claims, wherein said proteins are from at least three or four different plant sources.
5. The powder according to any of preceding claims, comprising at least 60 w/w % protein.
6. The powder according to any of preceding claims, comprising at least 70 w/w % protein.
7. The powder according to any of preceding claims, wherein said proteins are substantially intact.
8. The powder according to any of preceding claims, wherein said powder comprises less than 10 % fat.
9. The powder according to any of preceding claims, wherein said animal source is selected from the group consisting of fish, egg and milk.
10. The powder according to any of preceding claims, wherein said plant source is selected from the group consisting of spinaches, nuts, cauliflowers, broccolis, potatoes, rice, beans, and peas.
11. The powder according to any of preceding claims, wherein said plant source is potato, rice, soy bean and pea.
12. The powder according to any of preceding claims, comprising at least one of vitamins, trace elements, fibres, minerals and essential fatty acids.
13. A capsule, pellet or tablet comprising the powder according to any of preceding claims.
14. A food product comprising said powder according to any of preceding claims.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/139,944 US20110305798A1 (en) | 2008-12-17 | 2009-12-16 | Nutritional supplement with specific amino acid profile |
EP09833710A EP2373184A4 (en) | 2008-12-17 | 2009-12-16 | Nutritional supplement with specific amino acid profile |
Applications Claiming Priority (8)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
SE0802591 | 2008-12-17 | ||
SE0802591-8 | 2008-12-17 | ||
US15668709P | 2009-03-02 | 2009-03-02 | |
US61/156,687 | 2009-03-02 | ||
SE0900389-8 | 2009-03-26 | ||
SE0900389 | 2009-03-26 | ||
US16407209P | 2009-03-27 | 2009-03-27 | |
US61/164,072 | 2009-03-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2010071541A1 true WO2010071541A1 (en) | 2010-06-24 |
Family
ID=42269013
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/SE2009/000517 WO2010071541A1 (en) | 2008-12-17 | 2009-12-16 | Nutritional supplement with specific amino acid profile |
Country Status (3)
Country | Link |
---|---|
US (1) | US20110305798A1 (en) |
EP (1) | EP2373184A4 (en) |
WO (1) | WO2010071541A1 (en) |
Cited By (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103876204A (en) * | 2014-04-08 | 2014-06-25 | 广元天湟山核桃食品有限公司 | Humanized walnut milk and preparation method thereof |
FR3013186A1 (en) * | 2013-11-19 | 2015-05-22 | Roquette Freres | NOVEL NON-ALLERGENIC SNACKS CONTAINING PLANT PROTEINS |
EP2757898B1 (en) | 2011-09-20 | 2015-10-21 | Abbott Laboratories | Powdered nutritional formulations including spray-dried plant protein |
WO2015187817A3 (en) * | 2014-06-03 | 2016-07-21 | Abbott Laboratories | Potato based protein mixtures and nutritional compositions comprising potato protein |
EP2996487A4 (en) * | 2013-03-08 | 2016-10-19 | Axiom Foods Inc | Rice protein supplements |
US9820504B2 (en) | 2013-03-08 | 2017-11-21 | Axiom Foods, Inc. | Rice protein supplement and methods of use thereof |
CN109999056A (en) * | 2019-03-29 | 2019-07-12 | 湖北省八峰药化股份有限公司 | A kind of compound pellet and preparation method thereof containing a variety of amino acid, vitamine minerals |
US11684074B2 (en) | 2017-05-12 | 2023-06-27 | Axiom Foods, Inc. | Rice products and systems and methods for making thereof |
EP3852550B1 (en) * | 2018-09-17 | 2023-12-20 | Société des Produits Nestlé S.A. | Non-dairy drink with rice and pea proteins |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP3082453A1 (en) * | 2013-12-09 | 2016-10-26 | Abbott Laboratories | Nutritional compositions containing rice protein together with pea and/or potato proteins |
CN104187624B (en) * | 2014-08-07 | 2016-06-08 | 逯明福 | Comprehensive nutrition powder and its preparation method |
WO2016029074A1 (en) * | 2014-08-22 | 2016-02-25 | Abbott Laboratories | Nutritional beverage containing rice protein |
AU2016298354A1 (en) * | 2015-07-30 | 2018-02-01 | Oatly Ab | Vegetable health drink |
US10091986B2 (en) | 2016-05-09 | 2018-10-09 | Xor-Labs Toronto Inc. | Organ perfusion device and method |
CN113490424B (en) | 2019-02-26 | 2024-04-26 | 联合利华知识产权控股有限公司 | Edible composition comprising a structured aqueous phase |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4279917A (en) * | 1978-09-08 | 1981-07-21 | Ajinomoto Company, Incorporated | Amino acid solution for intravenous nutrition |
EP0034034A1 (en) * | 1980-02-08 | 1981-08-19 | Ajinomoto Co., Inc. | Nutrient composition |
EP0312612A1 (en) * | 1987-05-01 | 1989-04-26 | Otsuka Pharmaceutical Co., Ltd. | Nutritive emulsion |
EP0399656A1 (en) * | 1989-04-24 | 1990-11-28 | Kyowa Hakko Kogyo Kabushiki Kaisha | Nutrient compositions for amino acid supplementation in mammals |
EP1048226A1 (en) * | 1999-04-29 | 2000-11-02 | Société des Produits Nestlé S.A. | Infant formula containing sweet whey protein |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6511696B2 (en) * | 2000-12-13 | 2003-01-28 | Novartis Nutrition Ag | Infant formula with free amino acids and nucleotides |
JP4482925B2 (en) * | 2002-02-22 | 2010-06-16 | 味の素株式会社 | Amino acids powder and method for producing the same |
PT1799052E (en) * | 2004-09-09 | 2011-01-20 | Nestec Sa | Methods for the manufacture of nutritional products having improved quality |
PT1841330E (en) * | 2004-12-27 | 2011-03-14 | Nestec Sa | Use of infant formula with reduced protein content |
DK3485742T3 (en) * | 2006-11-29 | 2021-11-15 | Prolacta Bioscience Inc | BREAST MILK COMPOSITIONS AND METHODS OF MANUFACTURE AND USE |
-
2009
- 2009-12-16 WO PCT/SE2009/000517 patent/WO2010071541A1/en active Application Filing
- 2009-12-16 EP EP09833710A patent/EP2373184A4/en not_active Withdrawn
- 2009-12-16 US US13/139,944 patent/US20110305798A1/en not_active Abandoned
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4279917A (en) * | 1978-09-08 | 1981-07-21 | Ajinomoto Company, Incorporated | Amino acid solution for intravenous nutrition |
EP0034034A1 (en) * | 1980-02-08 | 1981-08-19 | Ajinomoto Co., Inc. | Nutrient composition |
EP0312612A1 (en) * | 1987-05-01 | 1989-04-26 | Otsuka Pharmaceutical Co., Ltd. | Nutritive emulsion |
EP0399656A1 (en) * | 1989-04-24 | 1990-11-28 | Kyowa Hakko Kogyo Kabushiki Kaisha | Nutrient compositions for amino acid supplementation in mammals |
EP1048226A1 (en) * | 1999-04-29 | 2000-11-02 | Société des Produits Nestlé S.A. | Infant formula containing sweet whey protein |
Non-Patent Citations (1)
Title |
---|
See also references of EP2373184A4 * |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2757898B1 (en) | 2011-09-20 | 2015-10-21 | Abbott Laboratories | Powdered nutritional formulations including spray-dried plant protein |
US9820504B2 (en) | 2013-03-08 | 2017-11-21 | Axiom Foods, Inc. | Rice protein supplement and methods of use thereof |
US10251415B2 (en) | 2013-03-08 | 2019-04-09 | Axiom Foods, Inc. | Rice protein supplement and methods of use thereof |
EP2996487A4 (en) * | 2013-03-08 | 2016-10-19 | Axiom Foods Inc | Rice protein supplements |
US9907331B2 (en) | 2013-03-08 | 2018-03-06 | Axiom Foods, Inc. | Rice protein supplement and methods of use thereof |
FR3013186A1 (en) * | 2013-11-19 | 2015-05-22 | Roquette Freres | NOVEL NON-ALLERGENIC SNACKS CONTAINING PLANT PROTEINS |
WO2015075378A1 (en) * | 2013-11-19 | 2015-05-28 | Roquette Freres | Novel non-allergenic snacks containing vegetable proteins |
RU2692654C2 (en) * | 2013-11-19 | 2019-06-25 | Рокетт Фрер | New non-allergenic light snacks containing vegetable proteins |
JP2016537004A (en) * | 2013-11-19 | 2016-12-01 | ロケット フレールRoquette Freres | Novel non-allergenic snacks containing plant proteins |
CN103876204B (en) * | 2014-04-08 | 2015-12-02 | 广元天湟山核桃食品有限公司 | A kind of breast milk Walnut Milk and preparation method thereof |
CN103876204A (en) * | 2014-04-08 | 2014-06-25 | 广元天湟山核桃食品有限公司 | Humanized walnut milk and preparation method thereof |
JP2017518078A (en) * | 2014-06-03 | 2017-07-06 | アボット・ラボラトリーズAbbott Laboratories | Potato-based protein mixture and nutritional composition containing potato protein |
WO2015187817A3 (en) * | 2014-06-03 | 2016-07-21 | Abbott Laboratories | Potato based protein mixtures and nutritional compositions comprising potato protein |
US11684074B2 (en) | 2017-05-12 | 2023-06-27 | Axiom Foods, Inc. | Rice products and systems and methods for making thereof |
EP3852550B1 (en) * | 2018-09-17 | 2023-12-20 | Société des Produits Nestlé S.A. | Non-dairy drink with rice and pea proteins |
CN109999056A (en) * | 2019-03-29 | 2019-07-12 | 湖北省八峰药化股份有限公司 | A kind of compound pellet and preparation method thereof containing a variety of amino acid, vitamine minerals |
Also Published As
Publication number | Publication date |
---|---|
US20110305798A1 (en) | 2011-12-15 |
EP2373184A1 (en) | 2011-10-12 |
EP2373184A4 (en) | 2012-08-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20110305798A1 (en) | Nutritional supplement with specific amino acid profile | |
US20120258236A1 (en) | Composition with high protein content for the food industry | |
US11612578B2 (en) | Nutritional composition for use in therapy of patients with sarcopenia and/or frailty or pre-sarcopenic and/or pre-frail patients | |
KR102276314B1 (en) | Method for Preparing Functional Mixed Concentrate Protein Extract and Plant based Meat Alternatives and Use thereof | |
JP2001120227A (en) | Diet food | |
KR19990063480A (en) | Compositions Effective in Reducing Obesity and Foods and Beverages Containing the Same | |
KR20210012963A (en) | Method for preparing Gryllus bimaculatus powder or extract thereof, food composition comprising the same and utilization thereof | |
CN110915925A (en) | Meal replacement milk shake solid beverage containing fruit and vegetable particles and having high protein and satiety and fat reduction effects | |
JP2005225874A (en) | Iron supplement and utilization of the same | |
JP2002020312A (en) | Food composition for promoting reduction in body fat and promoter for reduction in body fat | |
JP2017057147A (en) | Composition comprising garlic and the like, low-salinity miso, and vitamin b1 | |
WO2015137387A1 (en) | Muscle enhancing drug | |
JP7231898B2 (en) | sleep quality improver | |
CN114847492B (en) | Method for optimizing amino acid composition pattern, application, composition and nutritional supplement | |
JP2016214094A (en) | Green juice | |
CN109744479A (en) | A kind of turkey weight-reducing jerky and preparation method thereof | |
CN108208813A (en) | A kind of weight-reducing with health role disappears fat piece and preparation method thereof | |
CN108567118A (en) | It is a kind of to utilize fast food made of coarse cereals | |
JP2012082185A (en) | Collagens absorption promoter and its use | |
KR20100123377A (en) | Health foods composition for diet and muscle strengthening using chicken breast fresh | |
JP6884302B2 (en) | A composition for preventing fatigue, which comprises black garlic and miso having a Na content of 2.0 wt% or less. | |
JP2009084191A (en) | Pharmaceutical composition for inhibiting appetite | |
KR100805917B1 (en) | Spagetti sauce with squid viscera self-decomposition and manufacturing method thereof | |
KR102693582B1 (en) | Hypoallergenic whey protein hydrolysate and preparation method thereof | |
KR102660409B1 (en) | Stick-type nutritious snack for weight control for pets |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09833710 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009833710 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13139944 Country of ref document: US |